Thorsten Hagemann
Centre for Cancer and Inflammation
Institute of Cancer
Barts and The London School of Medicine and Dentistry
London EC1M 6BQ
UK
Name/email consistency: high
- "Re-educating" tumor-associated macrophages by targeting NF-kappaB. Hagemann, T., Lawrence, T., McNeish, I., Charles, K.A., Kulbe, H., Thompson, R.G., Robinson, S.C., Balkwill, F.R. J. Exp. Med. (2008)
- Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Hagemann, T., Robinson, S.C., Thompson, R.G., Charles, K., Kulbe, H., Balkwill, F.R. Mol. Cancer Ther. (2007)
- Inflammation and cancer: a double-edged sword. Hagemann, T., Balkwill, F., Lawrence, T. Cancer. Cell (2007)
- Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. Hagemann, T., Wilson, J., Burke, F., Kulbe, H., Li, N.F., Plüddemann, A., Charles, K., Gordon, S., Balkwill, F.R. J. Immunol. (2006)
- Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. Hagemann, T., Wilson, J., Kulbe, H., Li, N.F., Leinster, D.A., Charles, K., Klemm, F., Pukrop, T., Binder, C., Balkwill, F.R. J. Immunol. (2005)